Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

366 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Sirolimus and tacrolimus trough concentrations and dose requirements after kidney transplantation in relation to CYP3A5 and MDR1 polymorphisms and steroids.
Mourad M, Mourad G, Wallemacq P, Garrigue V, Van Bellingen C, Van Kerckhove V, De Meyer M, Malaise J, Eddour DC, Lison D, Squifflet JP, Haufroid V. Mourad M, et al. Among authors: mourad g. Transplantation. 2005 Oct 15;80(7):977-84. doi: 10.1097/01.tp.0000174131.47469.d2. Transplantation. 2005. PMID: 16249748 Clinical Trial.
Acute respiratory failure in kidney transplant recipients: a multicenter study.
Canet E, Osman D, Lambert J, Guitton C, Heng AE, Argaud L, Klouche K, Mourad G, Legendre C, Timsit JF, Rondeau E, Hourmant M, Durrbach A, Glotz D, Souweine B, Schlemmer B, Azoulay E. Canet E, et al. Among authors: mourad g. Crit Care. 2011;15(2):R91. doi: 10.1186/cc10091. Epub 2011 Mar 8. Crit Care. 2011. PMID: 21385434 Free PMC article.
Incidence of Posttransplantation Diabetes Mellitus in De Novo Kidney Transplant Recipients Receiving Prolonged-Release Tacrolimus-Based Immunosuppression With 2 Different Corticosteroid Minimization Strategies: ADVANCE, A Randomized Controlled Trial.
Mourad G, Glyda M, Albano L, Viklický O, Merville P, Tydén G, Mourad M, Lõhmus A, Witzke O, Christiaans MHL, Brown MW, Undre N, Kazeem G, Kuypers DRJ; Advagraf-based immunosuppression regimen examining new onset diabetes mellitus in kidney transplant recipients (ADVANCE) study investigators. Mourad G, et al. Among authors: mourad m. Transplantation. 2017 Aug;101(8):1924-1934. doi: 10.1097/TP.0000000000001453. Transplantation. 2017. PMID: 27547871 Free PMC article. Clinical Trial.
The effects of FK778 in combination with tacrolimus and steroids: a phase II multicenter study in renal transplant patients.
Vanrenterghem Y, van Hooff JP, Klinger M, Wlodarczyk Z, Squifflet JP, Mourad G, Neuhaus P, Jurewicz A, Rostaing L, Charpentier B, Paczek L, Kreis H, Chang R, Paul LC, Grinyó JM, Short C. Vanrenterghem Y, et al. Among authors: mourad g. Transplantation. 2004 Jul 15;78(1):9-14. doi: 10.1097/01.tp.0000132562.54089.62. Transplantation. 2004. PMID: 15257032 Clinical Trial.
[First acute rejection episode after renal transplantation: study of the histopathological characteristics according to the immunological risk].
Ghisdal L, Touchard G, Goujon JM, Buob D, Durand D, Mourad G, Lang P, Kessler M, Snanoudj R, Berthoux F, Merville P, Ouali N, Squifflet JP, Bayle F, Bourgeon B, Rifle G, Peeters P, Delahousse M, Legendre C, Bourbigot B, Noël C, Abramowicz D. Ghisdal L, et al. Among authors: mourad g. Nephrol Ther. 2008 Jun;4(3):173-80. doi: 10.1016/j.nephro.2008.02.001. Epub 2008 Apr 15. Nephrol Ther. 2008. PMID: 18417442 French.
FTY720, a novel immunomodulator: efficacy and safety results from the first phase 2A study in de novo renal transplantation.
Tedesco-Silva H, Mourad G, Kahan BD, Boira JG, Weimar W, Mulgaonkar S, Nashan B, Madsen S, Charpentier B, Pellet P, Vanrenterghem Y. Tedesco-Silva H, et al. Among authors: mourad g. Transplantation. 2004 Jun 27;77(12):1826-33. Transplantation. 2004. Corrected and republished in: Transplantation. 2005 Jun 15;79(11):1553-60. PMID: 15223899 Corrected and republished. Clinical Trial.
366 results